CTA approval: On 20 February 2026, Zelluna announced that the Medicines and Healthcare products Regulatory Agency (MHRA) and Research Ethics Committee (REC) had approved the Company’s Clinical Trial ...
A resident whose property is subject to expropriation under the Taoyuan Aerotropolis development project yesterday along with civic groups filed a petition for constitutional review of relevant ...
Thitu’s 400 residents serve as a civilian bulwark against Beijing’s territorial claims, with the population doubling in five ...
Preliminary safety and pharmacokinetic (PK) data from REC-1245, a potential first-in-class RBM39 degrader discovered and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results